Breaking through the Translation Barrier: Clinical Applications of Robotic Tech

Biomedical Engineering is aiming to develop novel medical technologies improving diagnosis and treatment of patients. The key issue is translation of the results into a viable and regulatory approved medical device. Not only that: reimbursement and successful clinal trials are further challenges. NICE recommendation in UK, MDR in Europe and FDA in USA and other countries are significant hurdles. Its estimated that 13-15 years are required to get a device to market. Patent protection last only 20 years.
During this year’s Clinical Forum we will have the opportunity to engage clinical and engineering experts in a lively discussion about the challenges and opportunities of translating medical technologies by exploring questions such as:

  • How could biomedical engineering and clinical sciences work together to enable effective translation?
  • How could a quality management system support translation?
  • How do we tackle patient interest and acceptance?
  • Who should pay for novel technologies?
  • How to deal with regulatory approval, clinical trials and reimbursement?


  1. Stan Anderson, Neurosurgeon, John’s Hopkins University, USA
  2. Kevin Cleary, BME, Childrens National Medical Centre, Washington DC
  3. Gernot Kronreif, BME, ACMIT GmbH, Austria
  4. Arianna Menciassi, BME, Sant’Anna School of Advanced Studies, Italy
  5. Mark Slack, Chief Medical Officer and Consultant Gynaecologist, CMR Surgical, UK


Andreas Melzer, MD DDS, ICCAS University Leipzig and IMSaT University Dundee, UK

 Date: Tuesday 27th June 2023 

 Time: 14:45 – 15:45